

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.pharmaceutical-technology.com/news/bms-acquires-forbius/
https://www.businesswire.com/news/canadacom/20200824005159/en/Bristol-Myers-Squibb-Enters-Agreement-Acquire-Forbius
https://www.biospace.com/article/releases/bristol-myers-squibb-enters-agreement-to-acquire-forbius-adding-lead-tgf-beta-asset-to-portfolio/?s=79
https://www.businesswire.com/news/home/20191108005112/en/Forbius-Completes-Phase-1-Oncology-Dose-Escalation-AVID200/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==
https://www.businesswire.com/news/home/20191010005243/en/Forbius-Phase-2-Clinical-Data-Tumor-Selective-Anti-EGFR/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==
https://www.businesswire.com/news/home/20190422005566/en/Forbius-Announces-Patient-Dosed-Phase-2a-EGFR-Overexpressing/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==